1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Quote. Delayed Nasdaq - 05/27 04:00:00 pm
147.66 USD   +8.73%
05/27Switzerland to Throw Out 620,000 Expired Moderna COVID-19 Vaccine Shots
MT
05/26ZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect
05/26INSIDER SELL : Moderna
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna To Start Clinical Development Of Vaccine Targeting Omicron Variant

01/17/2022 | 10:14am EDT


© MT Newswires 2022
All news about MODERNA, INC.
05/27Switzerland to Throw Out 620,000 Expired Moderna COVID-19 Vaccine Shots
MT
05/26ZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect
05/26INSIDER SELL : Moderna
MT
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care Stocks Falling This Afternoon
MT
05/25SECTOR UPDATE : Health Care
MT
05/25Bioquebec - moderna manufacturing facility opening in montreal
AQ
05/25French health body backs new COVID vaccine booster campaign for this autumn
RE
05/24Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
05/24GLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 069 M - -
Net income 2022 11 501 M - -
Net cash 2022 18 081 M - -
P/E ratio 2022 5,43x
Yield 2022 -
Capitalization 58 733 M 58 733 M -
EV / Sales 2022 1,84x
EV / Sales 2023 3,79x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 147,66 $
Average target price 214,33 $
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-41.86%58 733
LONZA GROUP AG-24.79%44 437
IQVIA HOLDINGS INC.-21.85%41 736
SEAGEN INC.-8.54%26 026
ICON PUBLIC LIMITED COMPANY-26.61%18 478
CELLTRION, INC.-21.21%17 245